The in vivo release study in mouse MI model indicated that the controlled release of SDF-1α from a PEGylated fibrin patch significantly recruited more c-kit + cells to the infarct area at the second week than did the direct injection group. The gene discussed is CXCL12; the disease is myocardial infarction.